Bank Of America Corp G1 Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 78,361 shares of GTHX stock, worth $560,281. This represents 0.0% of its overall portfolio holdings.

Number of Shares

78,361

Previous 379,011 79.32%

Holding current value

$560,281

Previous $1.64 Million 89.13%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.2 - $4.98 $661,430 - $1.5 Million	-300,650 Reduced 79.32%	78,361 $178,000
Q1 2024 May 15, 2024	BUY	$2.1 - $4.83 $209,059 - $480,836	99,552 Added 35.62%	379,011 $1.64 Million
Q4 2023 Feb 14, 2024	SELL	$1.12 - $3.73 $45,793 - $152,508	-40,887 Reduced 12.76%	279,459 $852,000
Q2 2023 Aug 14, 2023	SELL	$2.46 - $3.14 $696,357 - $888,846	-283,072 Reduced 46.91%	320,346 $797,000
Q1 2023 May 12, 2023	BUY	$2.57 - $8.16 $891,923 - $2.83 Million	347,052 Added 135.37%	603,418 $1.62 Million
Q4 2022 Feb 10, 2023	SELL	$5.19 - $13.5 $413,061 - $1.07 Million	-79,588 Reduced 23.69%	256,366 $1.39 Million
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $418,258 - $1.37 Million	80,901 Added 31.72%	335,954 $4.2 Million
Q2 2022 Aug 12, 2022	SELL	$4.04 - $8.51 $434,380 - $914,995	-107,520 Reduced 29.65%	255,053 $1.26 Million
Q1 2022 May 16, 2022	SELL	$7.6 - $11.02 $76,965 - $111,599	-10,127 Reduced 2.72%	362,573 $2.76 Million
Q4 2021 Feb 08, 2022	BUY	$10.16 - $16.17 $1.01 Million - $1.61 Million	99,335 Added 36.34%	372,700 $3.8 Million
Q3 2021 Nov 15, 2021	SELL	$13.16 - $22.47 $898,472 - $1.53 Million	-68,273 Reduced 19.98%	273,365 $3.67 Million
Q2 2021 Sep 13, 2021	BUY	$19.57 - $26.32 $6.69 Million - $8.99 Million	341,638 New	341,638 $7.5 Million

Others Institutions Holding GTHX

# of Institutions

Shares Held

18.2M

Call Options Held

1.85M

Put Options Held

1.18M

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp G1 Therapeutics, Inc. Transaction History